With health care reform, Congress is prepping to reshape roughly one-sixth of the economy. When a final health care bill emerges, it will almost certainly run hundreds of pages and could dictate the fortunes of everyone from hospitals to software companies.
Big pharmaceutical and insurance companies have poured millions of dollars into lobbying over the broad strokes of the legislation. But even the details will send shocks through smaller players across the country, and they’re spending money on K Street, too.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
